September 18, 2025
September 10, 2025
July 3, 2025
January 10, 2025
Rubicon Research Limited IPO 2025: Date, Lot Size & Subscription Overview
Author
Shoonya Team
The Rubicon Research Limited IPO will open on October 9, 2025, and will close on October 13, 2025. Through this IPO, Rubicon Research Limited aims to collect ₹1377.50 crores from the public.
The company is issuing 1.03 crore new shares to raise ₹500.00 crores. An additional 1.81 crore shares are being sold by existing shareholders, amounting to ₹877.50 crores.
MUFG Intime India Pvt. Ltd. has been appointed as the registrar for this issue.
Rubicon Research Limited IPO shares are priced between ₹461 and ₹485 per share. Investors can expect the allotment of the IPO for Rubicon Research Limited to be finalised on Tuesday, October 14, 2025.
Rubicon Research Limited IPO is tentatively scheduled to list on the BSE and NSE platforms on Thursday, October 16, 2025.
Check the steps to apply for the Rubicon Research Limited IPO
Rubicon Research Limited BSE NSE IPO Details
| Detail | Information |
| IPO Opening Date | October 9, 2025 |
| IPO Closing Date | October 13, 2025 |
| Tentative IPO Listing Date | October 16, 2025 |
| Face Value | ₹1 per share |
| Price Range | ₹461 to ₹485 per share |
| Lot Size | 30 shares |
| Total Issue Size | 28402040 Shares (1377.50 Cr.) |
| IPO Segment | Book Building Issue |
| Listing At | BSE NSE |
| Shareholding Pre-Issue | 154437251 shares |
| Shareholding post-issue | 164746529 shares |
| Registrar of Rubicon Research Limited | MUFG Intime India Pvt. Ltd. |
Rubicon Research Limited | Company Overview
Established in 1999, Rubicon Research Limited is a pharmaceutical company specializing in the development, manufacturing, and commercialization of differentiated formulations for global markets.
As of June 30, 2025, the company’s portfolio includes 72 approved products (comprising Abbreviated New Drug Applications, ANDAs and New Drug Applications NDAs) authorized by the US FDA.
Of these, 66 products are already commercialized, serving a combined US generic market valued at USD 2,455.7 million, with Rubicon contributing USD 195 million in revenue during Fiscal 2024.
Rubicon Research currently has 17 products pending FDA approval and 63 others under various stages of development.
The company markets over 350 SKUs to 96 customers, including three major wholesalers who collectively account for more than 90% of wholesale drug distribution in the US. Its customer network also spans group purchasing organizations (GPOs), national and regional pharmacy chains, and managed care organizations.
Beyond the US, Rubicon has registered or filed 48 product applications across key international markets such as Australia, the UK, Singapore, Saudi Arabia, and the UAE, with commercial rollouts expected post-approval.
Rubicon Research Limited IPO | Key Details
- Rubicon Research Limited IPO Opening Date: October 9, 2025,
- Rubicon Research Limited IPO Closing Date: October 13, 2025.
- Rubicon Research Limited IPO Allotment Date: October 14, 2025
- Rubicon Research Limited IPO Price Band: ₹461 to ₹485 per share
- Rubicon Research Limited IPO Lot Size: 30 shares
- Refunds Initiated: October 15, 2025
- Shares Credited to Demat: October 15, 2025
- Rubicon Research Limited Listing Date: October 16, 2025
Rubicon Research Limited: Financial Overview
Rubicon Research Limited’s revenue increased by 49%, and profit after tax (PAT) rose by 48% during FY25.
Here’s a summary of the financials:
Amounts in ₹ Crore
| Financial Information | 31-Mar-25 | 31-Mar-24 |
| Assets | 1451.43 | 1109.49 |
| Revenue | 1296.22 | 872.39 |
| Profit After Tax | 134.36 | 91.01 |
| EBITDA | 267.89 | 173.09 |
| Net Worth | 540.98 | 385.00 |
| Reserves & Surplus | 525.57 | 369.79 |
| Total Borrowing | 393.17 | 396.41 |
Rubicon Research Limited IPO | FAQs
Rubicon Research Limited is a specialty pharmaceutical company that develops and manufactures drug formulations and drug-device combinations especially for the U.S market.
The tentative IPO listing date of Rubicon Research Limited has been scheduled for Thursday, 16 October 2025.
The bidding date for Rubicon Research Limited’s IPO is October 9, 2025, and it will continue until October 13, 2025.
The minimum IPO lot size for Rubicon Research Limited is 30 shares.
The IPO allotment for Rubicon Research Limited is expected to be finalised on Tuesday, October 14, 2025.
The IPO face value for Rubicon Research Limited is set at ₹1 per share.
The allotment status of the Rubicon Research Limited IPO can be checked on the registrar’s website, MUFG Intime India Pvt. Ltd.
Disclaimer: Investments in the securities market are subject to market risks; read all the related documents carefully before investing.
Explore Our Offerings
Stocks
Trade equities across NSE and BSE with zero delivery charges. Invest, hold or sell with a seamless experience.
Future & Options
Execute complex strategies with simple tools and real-time data.
IPOs
Apply to the latest IPOs in just a few taps. Stay updated and capture opportunities as they open.